Cargando…
Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis
BACKGROUND AND OBJECTIVE: A proportion of patients with fibrotic hypersensitivity pneumonitis (fHP) follow a progressive disease course despite immunosuppressive treatment. Little is known about predictors of mortality in fHP. We aimed to investigate the impact of short‐term lung function changes in...
Autores principales: | Macaluso, Claudio, Boccabella, Cristina, Kokosi, Maria, Sivarasan, Nishanth, Kouranos, Vasilis, George, Peter M., Margaritopoulos, George, Molyneaux, Philip L., Chua, Felix, Maher, Toby M., Jenkins, Gisli R., Nicholson, Andrew G., Desai, Sujal R., Devaraj, Anand, Wells, Athol U., Renzoni, Elisabetta A., Stock, Carmel J. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302621/ https://www.ncbi.nlm.nih.gov/pubmed/35023231 http://dx.doi.org/10.1111/resp.14204 |
Ejemplares similares
-
Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management
por: Kouranos, Vasileios, et al.
Publicado: (2017) -
Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis
por: Jacob, Joseph, et al.
Publicado: (2018) -
P249 Predictors of adverse outcome in sarcoidosis complicated by chronic pulmonary aspergillosis
por: Nwankwo, Lisa, et al.
Publicado: (2022) -
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
por: Stock, Carmel J. W., et al.
Publicado: (2020) -
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
por: Invernizzi, Rachele, et al.
Publicado: (2021)